JAZZ Financial Facts
Product sales, net: 194.65MSelling, general and administrative: 70.53M
See Full Income Statement
See Full Balance Sheet
Earnings History for Jazz Pharmaceuticals, Inc. (JAZZ)
|
Expand Research on JAZZ
| Next EPS Date | 8/6/13 *Est. | EPS Growth Rate | +50.5% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/13  |
Q113 | $1.37 | $1.35 | +$0.02 | $196.2M | $189.92M | N/A / N/A |  |
+7.1% | Details | |
| 2/26/13 |
 |
Q412 | $1.53 | $1.42 | +$0.11 | $183.7M | $183.8M | N/A / N/A | |
+11.8% | Details |
| 11/8/12 |
|
Q312 | $1.29 | $1.32 | -$0.03 | $175.5M | $179.62M | $1.32 / $180.59M | = | +19.7% | Details |
| 8/7/12 |
|
Q212 | $1.09 | $1.05 | +$0.04 | $130M | $125.53M | $1.04 / $125.66M | = | +30.1% | Details |
| 5/8/12 |
Q112 | $0.91 | $0.84 | +$0.07 | N/A | $102.48M | N/A / N/A | = | +26.6% | Details | |
| 2/27/12 |
|
Q411 | $1.17 | $1.09 | +$0.08 | $83.5M | $80.84M | N/A / N/A | = | +26.2% | Details |
| 11/1/11 |
|
Q311 | $0.94 | $0.94 | $0.00 | $73.3M | $72.03M | N/A / N/A | |
+68.7% | Details |
| 7/28/11 |
|
Q211 | $0.82 | $0.77 | +$0.05 | $64.6M | $61.86M | N/A / N/A | |
+80.7% | Details |
